MedPath

Analgesic effect of paracetamol and meperidine after cesarean section.

Phase 3
Conditions
Cesarean delivery.
Single delivery by caesarean section
Registration Number
IRCT201405262624N17
Lead Sponsor
Vice chancellor for research ,Iran University of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

all patients after cesarean section with normal body mass index( between 18.5 and 25).
Exclusion criteria: Drug abuse; history of allergy to paracetamol or mepiridine; history of hepatitis; renal failure; heart failure; respiratory disease;CNS disorders; coagulopathy; sedative use; psychiatric disorders and complication of cesarean section.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain . Timepoint: 0-1-2-4 and 6 hours after drug administration. Method of measurement: VAS.
Secondary Outcome Measures
NameTimeMethod
eed to more analgesic. Timepoint: 0-1-2-4 and 6 hours after drug administration. Method of measurement: questionair.;Paracetamol adverse effects. Timepoint: 0-1-2-4 and 6 hours after drug administration. Method of measurement: VAS.;Side effects of meperidine. Timepoint: 0-1-2-4 and 6 hours after drug administration. Method of measurement: VAS.
© Copyright 2025. All Rights Reserved by MedPath